Get startedLog in
    Picture of Egetis Therapeutics AB (publ) logo

    EGTX — Egetis Therapeutics AB (publ) News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeSmall CapMomentum Trap
    All News

    Brief: PledPharma: Aladote Concluded As Safe In First Clinical Study

    Picture of Egetis Therapeutics AB (publ) logoEgetis Therapeutics AB (publ)
    25/06/2018 07:38
    June 25 (Reuters) - PledPharma AB (publ)  PLED.ST :
    * REG-ALADOTE® IS CONCLUDED AS SAFE IN FIRST CLINICAL STUDY
–
PLEDPHARMA AIMS TO APPLY FOR ORPHAN DRUG STATUS IN THE US
    * COMPLETE RESULTS  WILL BE AVAILABLE IN SEPTEMBER 2018

Source text for Eikon:  ID:nGNE2ysWl6 
Further company coverage:  PLED.ST 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))

    Recent news on Egetis Therapeutics AB (publ)

    See all news